Householder Group Estate & Retirement Specialist’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-456
Closed -$66K 828
2024
Q3
$66K Sell
456
-36
-7% -$5.21K 0.02% 437
2024
Q2
$67K Hold
492
0.02% 430
2024
Q1
$67.6K Hold
492
0.02% 425
2023
Q4
$66K Buy
492
+1
+0.2% +$122 0.02% 409
2023
Q3
$60.1K Buy
+491
New +$62.4K 0.02% 406
2023
Q1
$63K Buy
+492
New +$64.4K 0.02% 394
2022
Q4
Sell
-645
Closed -$75K 663
2022
Q3
$75K Buy
+645
New +$80.1K 0.03% 316

Other funds holding IBB

Householder Group Estate & Retirement Specialist's IBB Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 456 shares — an estimated $66K sold.

Householder Group Estate & Retirement Specialist first reported a position in IBB in Q3 2022 and held it in 7 quarters. The position peaked at $75K in Q3 2022. 875 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • Householder Group Estate & Retirement Specialist reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 456 iShares Biotechnology ETF shares in Q4 2024, an estimated $66K.
  • Householder Group Estate & Retirement Specialist first reported a position in iShares Biotechnology ETF in Q3 2022 and held it in 7 quarters.
  • Householder Group Estate & Retirement Specialist's iShares Biotechnology ETF position peaked at $75K in Q3 2022.
  • 875 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.